Table of Contents

company-logo

SciSparc Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea, and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for the treatment of autism spectrum disorder and epilepsy. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and CannAmide, a palmitoylethanolamide oral tablet in soft gel capsule form. It also has an agreement with the Sheba Fund for Health Services and Research to examine the potential role of SCI-210 for the treatment of status epilepticus; and The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.

SciSparc Dividend Announcement

• SciSparc does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on SciSparc dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

SciSparc Dividend History

SciSparc Dividend Yield

SciSparc current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing SciSparc stock? Use our calculator to estimate your expected dividend yield:

SciSparc Financial Ratios

P/E ratio-0.02
PEG ratio0.00
P/B ratio0.01
ROE-87.48%
Payout ratio0.00%
Current ratio4.10
Quick ratio3.63
Cash Ratio1.36

SciSparc Dividend FAQ

Does SciSparc stock pay dividends?
SciSparc does not currently pay dividends to its shareholders.
Has SciSparc ever paid a dividend?
No, SciSparc has no a history of paying dividends to its shareholders. SciSparc is not known for its dividend payments.
Why doesn't SciSparc pay dividends?
There are several potential reasons why SciSparc would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will SciSparc ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While SciSparc has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is SciSparc a dividend aristocrat?
SciSparc is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is SciSparc a dividend king?
SciSparc is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is SciSparc a dividend stock?
No, SciSparc is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy SciSparc stocks?
To buy SciSparc you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy SciSparc stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.